诚益通涨2.09%，成交额5755.27万元，主力资金净流出99.62万元

Group 1 - The core viewpoint of the news is that Chengyitong's stock has shown fluctuations in price and trading volume, with a current market value of 5.202 billion yuan and a year-to-date increase of 24.88% [1][2] - As of December 19, the stock price increased by 2.09% to 19.05 yuan per share, with a trading volume of 57.55 million yuan and a turnover rate of 1.18% [1] - The company has experienced a net outflow of 996,200 yuan in principal funds, with large orders accounting for 10.85% of purchases and 12.58% of sales [1] Group 2 - Chengyitong's main business includes providing automation control solutions for the pharmaceutical and biotechnology industries, with revenue contributions of 54.65% from control systems, 28.89% from rehabilitation medical devices, and 16.47% from system equipment and others [2] - The company reported a revenue of 633 million yuan for the first nine months of 2025, a year-on-year decrease of 20.40%, and a net profit attributable to shareholders of 67.83 million yuan, down 30.83% year-on-year [2] - The number of shareholders as of September 30, 2025, was 32,000, a decrease of 1.94% from the previous period, with an average of 8,110 circulating shares per person, an increase of 1.98% [2] Group 3 - Chengyitong has distributed a total of 80.55 million yuan in dividends since its A-share listing, with 39.60 million yuan distributed in the last three years [3] - As of September 30, 2025, new institutional shareholders include Changcheng Consumption Value Mixed A, holding 2 million shares, and Guangfa Jufeng Mixed A, holding 1.33 million shares, while Huaxia Leading Stock has exited the top ten circulating shareholders [3]